|
|
|
40
|
0051F
|
CAPECITABINE 150MG TAB (INP/AHI)
|
CAPECITABINE
|
CAPECITABINE
|
6X10
|
BQ
|
194.20
|
3.24
|
TABLET
|
0
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
0051M
|
CAPECITABINE 150MG TAB (INP)
|
CAPECITABINE
|
CAPECITABINE
|
10'S
|
BQ
|
15.79
|
1.58
|
TAB
|
230
|
PACK
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0582B
|
CYTARABINE 1G INJ (INP/AHI)
|
CYTARABINE
|
CYTARABINE
|
1G VIAL
|
BQ
|
38.46
|
38.46
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0631AD
|
METHOTREXATE 2.5MG TAB (INP/AHI)
|
METHOTREXATE
|
METHOTREXATE
|
100'S
|
A
|
12.72
|
0.13
|
TABLET
|
32
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0633V
|
METHACOR 25MG/ML INJ (INP/AHI) METHOTREXATE
|
METHOTREXATE
|
METHACOR
|
2ML VIAL
|
B
|
8.70
|
8.70
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0634M
|
METHOTREXATE 25MG/ML INJ (INP/AHI)
|
METHOTREXATE
|
METHOTREXATE
|
20ML VIAL
|
BQ
|
46.43
|
46.43
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
06351
|
METHOTREXATE 25MG/ML INJ (INP/AHI)
|
METHOTREXATE
|
METHOTREXATE
|
40ML
|
BQ
|
82.12
|
82.12
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
06417
|
ACCORD MITOMYCIN 5MG INJ (INP/AAL) MITOMYCIN
|
MITOMYCIN
|
ACCORD MITOMYCIN
|
5MG VIAL
|
BQ
|
203.06
|
203.06
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
11045
|
ACCORD PROPRANOLOL 80MG TAB (INP/AAL)
|
PROPRANOLOL
|
ACCORD PROPRANOLOL
|
56'S
|
A
|
13.40
|
0.24
|
TABLET
|
150
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
1131FW
|
LIPITAS 10MG TAB (INP/AHI) ATORVASTATIN
|
ATORVASTATIN
|
LIPITAS
|
30'S
|
A
|
3.56
|
0.1187
|
TABLET IMMED
|
|
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2023-03-20
|
2024-03-31
|
Add to Contract as Cat A
|
Oral
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
2023-01-04
|
|
|
|
41
|
1131GT
|
ATORVASTATIN 10MG TAB (INP)
|
ATORVASTATIN
|
ATORVASTATIN
|
1000'S
|
A
|
35.96
|
0.036
|
TAB
|
30
|
BOTT
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
1132HE
|
LIPITAS 20MG TAB (INP/AHI) ATORVASTATIN
|
ATORVASTATIN
|
LIPITAS
|
30'S
|
A
|
4.32
|
0.144
|
TABLET IMMED
|
30
|
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2023-03-20
|
2024-03-31
|
Add to Contract as Cat A
|
Oral
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
2023-01-04
|
|
|
|
40
|
1133FV
|
LIPITAS 40MG TAB (INP/AHI) ATORVASTATIN
|
ATORVASTATIN
|
LIPITAS
|
30'S
|
A
|
5.41
|
0.1803
|
TABLET IMMED
|
30
|
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2023-03-20
|
2024-03-31
|
Add to Contract as Cat A
|
Oral
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
2023-01-04
|
|
|
|
40
|
1601AL
|
ACCORD DIAZEPAM 2MG TAB (INP/AAL) DIAZEPAM
|
DIAZEPAM
|
ACCORD DIAZEPAM
|
30'S
|
A
|
2.34
|
0.08
|
TABLET
|
120
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
282408
|
BENZODIAZEPINES (SEDATIVES)
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
1603AK
|
ACCORD DIAZEPAM 10MG TAB (INP/AAL) DIAZEPAM
|
DIAZEPAM
|
ACCORD DIAZEPAM
|
30'S
|
A
|
3.67
|
0.12
|
TABLET
|
60
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
282408
|
BENZODIAZEPINES (SEDATIVES)
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
1612S
|
DOCETAXEL 80MG INJ (INP/AHI)
|
DOCETAXEL
|
DOCETAXEL
|
80MG VIAL
|
C
|
65.70
|
65.70
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
1932AK
|
INTAGRA 50MG TAB (INP/AHI) SILDENAFIL
|
SILDENAFIL
|
INTAGRA
|
4'S
|
BQ
|
1.20
|
0.30
|
TABLET
|
0
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
241212
|
PHOSPHODIESTERASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1932AK
|
INTAGRA 50MG TAB (INP) SILDENAFIL (BQ)
|
SILDENAFIL
|
INTAGRA
|
4'S
|
BQ
|
0.95
|
0.2378
|
TAB
|
30
|
BOX
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
241212
|
PHOSPHODIESTERASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
PHOSPHODIESTERASE INHIBITORS
|
|
|
|
|
40
|
19536
|
IBANDRONIC ACID 1MG/ML INJ (INP/AAL)
|
IBANDRONIC ACID
|
IBANDRONIC ACID
|
6ML VIAL
|
C
|
9.51
|
9.51
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
2841DL
|
ZOMET 500MG TAB (INP) METFORMIN
|
METFORMIN
|
ZOMET
|
10X10
|
A
|
4.08
|
0.0408
|
TAB
|
180
|
BOX
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
682004
|
BIGUANIDES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
BIGUANIDES
|
|